National Jewish Health

Medications

New monoclonal antibody shows promise for severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health ...

Health

Examining the adverse effects of hand sanitizers

Washing hands and using hand sanitizer have been some of the most important methods to combat spread of infection during the COVID-19 pandemic. Reports of increased hand irritation and dryness prompted a study led by researchers ...

Diseases, Conditions, Syndromes

New guidelines clarify diagnosis of hypersensitivity pneumonitis

The American College of Chest Physicians has published new guidelines for the diagnosis and evaluation of hypersensitivity pneumonitis (HP), an interstitial lung disease characterized by scarring and/or inflammation of the ...

Immunology

Replacement with non-allergenic joints can provide relief

Allergies to metals used in artificial joint hardware, or to the bone cement used to secure them, can cause severe pain, itching, swelling and loosening of the joint, according to research at National Jewish Health. Replacement ...

Medical research

Allergic asthma transforms cells of the airway

New research at National Jewish Health shows that allergic asthma fundamentally transforms the human airway, reducing cells' ability to remove pollutants and fight infections. Allergic asthma, the most common form of the ...

page 3 from 9